Sapien biobank evaluates novel drug candidates and formulations for global biotech and pharma companies using our proprietary panel of live cells and 3Dcellculture derived from cancer surgeries tissues. These are also called patient-derived cells or PDCs. Assays using PDCs are very valuable before going to clinical trials. We are delighted that our work done with a novel formulation in triple negative breastcancer (TNBC) proliferation and stemcell viability was included for the presentation at AACR.
Tag Archive for: pharma
NIPER Hyderabad had a star-studded Academia-Industry Synergy day on 23rd Aug, 2018. I was asked to moderate apanel on Innovation and Entrepreneurship. I chose to focus on the aspect of driving innovation already at NIPER-H towards commercialization. Invited Dr. Ashutosh of NIPER to identify where the gaps are, and put them to a panel of seasoned people drawn from industry in different areas of expertise spanning from technology transfer, chemistry, determining cell and animal model activity, development of pharmaceutical properties etc.
In the picture above, taken with the Director of NIPER, from left to right, my expert panellists were
- a) Sreenivas, ex-P&G, ex-Lilly, who started Sreeni Labs 11 years ago,
- b) Suresh Poosala, ex-BMS who just started OncoSeek Bio,
- c)Myself, ex-Vertex, who co-founded Sapien Biosciences and Saarum Sciences,
- d) Shashi Bala Singh, Director of NIPER-Hyd
- e) Anil Wali, FIIT
- f) Hemant Bhutani, ex-NIPER-Mohali, BMS-BBRC
- g) Ashutosh Kumar, ex-NIPER-Mohali, Associate Professor at NIPER-H
Dr. Suman Kapur of BITS-Pilani Hyd, had to leave early but she shared her challenges and experience of developing point of care diagnostic devices.
Many useful suggestions came from not just the panel but also students and members of the audience. These will be compiled and used to continue the dialogue with NIPER-H to see how best to implement them.
1st Floor, AIMSR Building,
Apollo Health City,
Hyderabad 500 096